Relación entre carcinoma hepatocelular, síndrome metabólico y la enfermedad grasa no alcohólica del hígado

Chirinos, Jesús L.
July 2013
Revista Medica Herediana;jul-sep2013, Vol. 24 Issue 3, p260
Academic Journal
No abstract available.


Related Articles

  • New Trends and Novel Treatment for Hepatocellular Carcinoma: A Global Perspective. ZHU, ANDREW X.; CHABNER, BRUCE A.; TANABE, KENNETH K. // Oncologist;Nov2010 Supplement, Vol. 15, p1 

    An introduction to the journal is presented in which the editor discusses various reports published within the issue including one by Venook and colleagues on global epidemiological trends of hepatocellular carcinoma (HCC), one by Sanyal and colleagues on various risk factors associated with...

  • Erratum.  // Journal of the Korean Medical Association / Taehan Uisa Hyophoe ;Dec2013, Vol. 56 Issue 12, p1189 

    No abstract available.

  • Erratum.  // Oncology;Aug2016, Vol. 91 Issue 2, p116 

    A correction to the article "Validation of a preclinical model of diethylnitrosamine-induced hepatic neoplasia in Yucatan miniature pigs" which appeared in a 2016 issue is presented.

  • Erratum.  // International Journal of Cancer;Apr2020, Vol. 146 Issue 7, pE28 

    No abstract available.

  • Trends and Practices in Diagnosis and Treatment of Hepatocellular Carcinoma. Brewer, Patricia // Radiologic Technology;Jan/Feb2013, Vol. 84 Issue 3, p301 

    The article reviews "Trends and Practices in Diagnosis and Treatment of Hepatocellular Carcinoma," an International Atomic Energy Agency (IAEA) Human Health Series publication 2010.

  • Beyond Barcelona, a review of the expansion of the current treatment guidelines for hepatocellular carcinoma. Sargent, Suzanne // Gastrointestinal Nursing;2015 Supplement, Vol. 13 Issue Sup9, pS6 

    The article examines the expansion of treatment guidelines for hepatocellular carcinoma (HCC). Topics discussed include the increasing incident rate of liver cancer inclusive of hepatic carcinoma in the West and the use of evidence-based guidelines for treating HCC with tumor staging determined...

  • Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin. Johnson, P.J.; Wansbrough-Jones, M.H.; Portmann, B.; Eddleston, A.L.W.; Williams, Roger; Maycock, W. d'A.; Calne, R.Y. // British Medical Journal;1/28/1978, Vol. 1 Issue 6107, p216 

    Reports of familial hepatoma, particularly those associated with HBsAg, are rare.[1-3] In the present family two of three brothers, both positive for HBsAg, have so far developed a hepatoma. One treated by liver transplantation received large doses of specific immunoglobulin to prevent...

  • Thalassaemia minor, iron overload, and hepatoma. Parfrey, P.S.; Squier, Marian // British Medical Journal;2/18/78, Vol. 1 Issue 6110, p416 

    Although haemochromatosis has been described in association with several chronic haemolytic anaemias, such patients have usually received many blood transfusions. Iron overload has been rarely reported in thalassaemia minor in the absence of exogenous iron.[1] Hepatocellular carcinoma occurs in...

  • Efficacy And Safety Of Raltitrexed Plus Oxaliplatin-Based Transarterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma. Shao, Wenbo; Li, Caixia; Tang, Jun; Song, Jinlong; Li, Zixiang; Sun, Jize; Xu, Yili; Zheng, Zhaomin; Cao, Jingqin; Zhang, Lei // Cancer Management & Research;Nov2019, Vol. 11, p9863 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics